Home > Income Statement > ERIS LIFESCIENCES

ERIS LIFESCIENCES
Revenue

    Back to Income Statement
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

ERIS LIFESCIENCES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹2,009 Cr₹16,851 Cr₹1,347 Cr₹1,212 Cr₹1,074 Cr

What is the latest Revenue of ERIS LIFESCIENCES ?

The latest Revenue ratio of ERIS LIFESCIENCES is ₹2,009 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹2,009 Cr
Mar2024₹16,851 Cr
Mar2023₹1,347 Cr
Mar2022₹1,212 Cr
Mar2021₹1,074 Cr

How is Revenue of ERIS LIFESCIENCES Trending?

Years Revenue % Change
Mar2025 ₹2,009 Cr
-88.08
Mar2024 ₹16,851 Cr
1,151.00
Mar2023 ₹1,347 Cr
11.15
Mar2022 ₹1,212 Cr
12.83
Mar2021 ₹1,074 Cr -

Compare Revenue of peers of ERIS LIFESCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ERIS LIFESCIENCES ₹18,423.3 Cr -0.6% -2.1% -0% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


ERIS LIFESCIENCES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ERIS LIFESCIENCES

-0.6%

-2.1%

-0%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses